FDA Updates COVID-19 Test Policy and FAQs

Home
FDA Updates COVID-19 Test Policy and FAQs

October 10, 2022 Center for Disease Control

Tweet

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.

On September 27, 2022, the CDC alerted laboratories that the Food and Drug Administration had updated its COVID-19 test policy to encourage most test developers to pursue a traditional premarket review pathway for their tests rather than emergency authorization.

FDA Updates COVID-19 Test Policy and FAQs October 10, 2022
CDC Issues Select Agent Gram for Monkeypox Virus October 10, 2022
HHS Declaration of Public Health Emergency for Monkeypox Diagnostics and New FDA Guidance October 10, 2022
Variant Influenza Virus Infections September 06, 2022
Best Practices for Suspected Monkeypox Lesion Specimen Collection September 05, 2022

FDA Updates COVID-19 Test Policy and FAQs October 10, 2022
CDC Issues Select Agent Gram for Monkeypox Virus October 10, 2022
HHS Declaration of Public Health Emergency for Monkeypox Diagnostics and New FDA Guidance October 10, 2022
Variant Influenza Virus Infections September 06, 2022
Best Practices for Suspected Monkeypox Lesion Specimen Collection September 05, 2022

Posts by Tag

CDC LOCS (4)

Search Blog:

Careers | Press Room

9881 Broken Land Pkwy Suite 200 | Columbia, MD 21046-3016
Phone (800) 981-9883 | Fax (410) 381-8611 | Email info@cola.org